617716-22-0 Usage
Description
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine is a heterocyclic organic compound with the molecular formula C7H4Cl2F2N2. It belongs to the pyrimidine class of chemicals and is a potential pharmaceutical intermediate used in the synthesis of pharmaceutical drugs. The cyclopropyl and fluorine groups in its structure contribute to its unique reactivity and biological activity.
Uses
Used in Pharmaceutical Industry:
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and reactivity make it a valuable compound for research and development in the pharmaceutical industry.
Used in Antimicrobial Applications:
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine is used as an antimicrobial agent due to its potential to inhibit the growth of certain microorganisms.
Used in Antiviral Applications:
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine is used as an antiviral agent, showing potential to inhibit the replication of certain viruses.
Used in Antitumor Applications:
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine is used as an antitumor agent, demonstrating potential to inhibit the growth and proliferation of cancer cells.
Check Digit Verification of cas no
The CAS Registry Mumber 617716-22-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,7,7,1 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 617716-22:
(8*6)+(7*1)+(6*7)+(5*7)+(4*1)+(3*6)+(2*2)+(1*2)=160
160 % 10 = 0
So 617716-22-0 is a valid CAS Registry Number.
617716-22-0Relevant articles and documents
First dual M3 antagonists-PDE4 inhibitors: Synthesis and SAR of 4,6-diaminopyrimidine derivatives
Provins, Laurent,Christophe, Bernard,Danhaive, Pierre,Dulieu, Jacques,Durieu, Véronique,Gillard, Michel,Lebon, Florence,Lengelé, Sébastien,Quéré, Luc,Van Keulen, Berendjan
, p. 1834 - 1839 (2007/10/03)
SAR around 4,6-diaminopyrimidine derivatives allowed the discovery of the first potent dual M3 antagonists and PDE4 inhibitors. Various chemical modulations around that scaffold led to the discovery of ucb-101333-3 which is characterized by the
